Ates O - Search Results

1

HIPEC in Ovarian Cancer: When and to Whom?

Ates O, Aksel B, Akkus MH, Oner I, Yuksel C, Dogan M. Ates O, et al. J Coll Physicians Surg Pak. 2023 Sep;33(9):1001-1005. doi: 10.29271/jcpsp.2023.09.1001. J Coll Physicians Surg Pak. 2023. PMID: 37691361

2

Clinical Outcomes and Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: A Single-centre Experience.

Karakaya S, Karadag I, Ates O, Cakmak Oksuzoglu OB, Demirci U. Karakaya S, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2021 Feb;31(2):166-170. doi: 10.29271/jcpsp.2021.02.166. J Coll Physicians Surg Pak. 2021. PMID: 33645183

3

CROSS or FLOT in Distal Esophageal and Gastroesophageal Cancer.

Karadag I, Karakaya S, Ates O, Cakmak Oksuzoglu OB. Karadag I, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2021 Mar;31(3):326-329. doi: 10.29271/jcpsp.2021.03.326. J Coll Physicians Surg Pak. 2021. PMID: 33775025

4

Platelet-to-Lymphocyte Ratio as an Indicator to Predict Decreased Carbon Monoxide Diffusion of the Lung in Patients with Testicular Cancer.

Karakaya S, Karadag I, Ozdilekcan C, Durmusoglu E, Ates O, Cakmak Oksuzoglu OB. Karakaya S, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2022 Mar;32(3):369-372. doi: 10.29271/jcpsp.2022.03.369. J Coll Physicians Surg Pak. 2022. PMID: 35148592

5

Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience.

Ates O, Aksel B, Karadag I, Karakaya S, Sunar V, Oksuzoglu OB. Ates O, et al. Indian J Cancer. 2024 Apr 1;61(2):305-311. doi: 10.4103/ijc.IJC_395_20. Epub 2022 Oct 12. Indian J Cancer. 2024. PMID: 36861708 Free article.

6

Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.

Özdemir Z, Çevik E, Öksüzoğlu ÖBÇ, Doğan M, Ateş Ö, Esin E, Bilgetekin İ, Demirci U, Köseoğlu Ç, Topal A, Karadurmuş N, Erdem HB, Bahsi T. Özdemir Z, et al. Among authors: ates o. Mutat Res. 2023 Jul-Dec;827:111831. doi: 10.1016/j.mrfmmm.2023.111831. Epub 2023 Jul 4. Mutat Res. 2023. PMID: 37453313

7

Efficacy and Safety of Combined Chemotherapy Regimens with Bevacizumab in Platinum-sensitive Ovarian Cancers.

Tay F, Buyukkor M, Ates O. Tay F, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2023 Sep;33(9):1006-1011. doi: 10.29271/jcpsp.2023.09.1006. J Coll Physicians Surg Pak. 2023. PMID: 37691362

8

Comparison of the Efficiency of Induction and Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer.

Buyukkor M, Tay F, Kurtulus A, Ates O. Buyukkor M, et al. Among authors: ates o. J Coll Physicians Surg Pak. 2023 Oct;33(10):1141-1147. doi: 10.29271/jcpsp.2023.10.1141. J Coll Physicians Surg Pak. 2023. PMID: 37804020

9

Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients.

Erdem HB, Alay MT, Özdemir Z, Çevik E, Ateş Ö, Karaçin C, Şahin İ, Doğan M, Bahsi T. Erdem HB, et al. Among authors: ates o. Mutat Res. 2024 Jan-Jun;828:111847. doi: 10.1016/j.mrfmmm.2023.111847. Epub 2023 Nov 28. Mutat Res. 2024. PMID: 38071953

10

Prognostic factors in non-metastatic HER2 'low' and HER2 'negative' breast cancer: single institute experience.

Türkel A, Doğan M, Sertesen E, Karaçin C, Irkkan SÇ, Ateş Ö. Türkel A, et al. Among authors: ates o. Wien Klin Wochenschr. 2024 Jun;136(11-12):340-346. doi: 10.1007/s00508-023-02315-z. Epub 2024 Jan 5. Wien Klin Wochenschr. 2024. PMID: 38180508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters